scholarly journals Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)

2010 ◽  
Vol 70 (5) ◽  
pp. 755-759 ◽  
Author(s):  
G. R. Burmester ◽  
E. Feist ◽  
H. Kellner ◽  
J. Braun ◽  
C. Iking-Konert ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Active Rheumatoid Arthritis ◽  
Real Life ◽  
Life Study ◽  
Phase Iiib ◽  
Interleukin 6 Receptor ◽  
Real Life Study

The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

2017 ◽  
Author(s):  
Ifigenia Kostoglou-Athanassiou ◽  
Lambros Athanassiou ◽  
Aikaterini Tzanavari ◽  
Charoula Katsavouni ◽  
Markos Kostopoulos ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Lipid Levels ◽  
Interleukin 6 Receptor

scholarly journals FRI0046 POLYPHARMACY: A RARELY-DISCUSSED PROBLEM IN RHEUMATOID ARTHRITIS. DATA FROM A LARGE REAL-LIFE STUDY

2019 ◽  
Author(s):  
Ana Paula Gomides ◽  
Cleandro Albuquerque ◽  
Ana Beatriz Vargas-Santos ◽  
Claiton Brenol ◽  
Ivanio Pereira ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Real Life ◽  
Life Study ◽  
Real Life Study ◽  
Rheumatoid Arthritis Data

AB0222 Body Mass Index, Smoking Status and Response To Rituximab in Rheumatoid Arthritis: A Real Life Study

2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 974.1-974
Author(s):  
M.C. Gerardi ◽  
A. Batticciotto ◽  
M. Antivalle ◽  
S. Bongiovanni ◽  
R. Talotta ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Body Mass Index ◽  
Body Mass ◽  
Smoking Status ◽  
Real Life ◽  
Life Study ◽  
Real Life Study
Sign in / Sign up

Export Citation Format

Share Document